Considering the World Health Organization (WHO) projections, mental health is one of the most crucial health and wellness areas so adopting new psychiatric treatments is ideal. One of these new avenues for treatment research is psychedelic medicine, such as MDMA and Psilocybin. At Pacific Pain & Wellness Group, we are researching the use of psychedelics in psychiatric treatment for patients with a variety of mental health conditions, include Post-Traumatic Stress Disorder (PTSD). We also studying the use of psychedelic medicine in managing conditions such as anxiety and depressive disorders connected to terminal illnesses.
In addition to mental health, our expert doctors are also investigating the use of psychedelic medicine in chronic pain management. The chronic pain mechanism hasn’t been fully understood yet. However, it has been established that the pain signals you experience over time lead to the central and peripheral nervous systems becoming sensitive. The sensitivity then transforms into an emotional and physical pain experience. Since the pain has both affective and physical components, psychedelic medicine alleviates chronic pain conditions like cluster headache, tinnitus, and phantom limb pain as part of the treatment procedure.
Research suggests that mind-changing qualities of psychedelics reset functional connectivity areas in the brain that play significant roles in making you experience the pain that originates from the central nervous system. Psychedelic medicine is a non-addictive alternative to opioids; hence, it represents a much-needed and revolutionary approach to pain management as well. If you are interested in being involved in this research, please contact us to learn more.